If preventable why not prevented?
作者信息
Gordan G S
出版信息
West J Med. 1980 Oct;133(4):331-3.
Abstract
摘要
相似文献
1
If preventable why not prevented?如果是可预防的，为何没有预防？
West J Med. 1980 Oct;133(4):331-3.
2
[Every third hip fracture can be prevented].每三例髋部骨折中就有一例是可以预防的。
Sygeplejersken. 1998 Feb 6;98(6):18-21.
3
[Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis].[雌激素及选择性雌激素受体调节剂在骨质疏松症治疗中的应用]
Ann Med Interne (Paris). 2000 Oct;151(6):490-6.
4
[Hip fractures--is the osteoporosis prophylaxis on the correct course?].髋部骨折——骨质疏松症预防措施是否正确？
Ugeskr Laeger. 2002 May 13;164(20):2597.
5
Osteoporosis.骨质疏松症
Prim Care. 2006 Dec;33(4):943-51, vii. doi: 10.1016/j.pop.2006.09.004.
6
Prevention and treatment of senile osteoporosis and hip fractures.老年骨质疏松症及髋部骨折的防治
Minerva Med. 2009 Feb;100(1):79-94.
7
Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.雌激素停用后髋部骨折保护作用迅速丧失：来自国家骨质疏松症风险评估的证据。
Obstet Gynecol. 2004 Mar;103(3):440-6. doi: 10.1097/01.AOG.0000114986.14806.37.
8
9
Inadequate dietary calcium intake in elderly patients with hip fractures.髋部骨折老年患者膳食钙摄入量不足。
Singapore Med J. 2007 Dec;48(12):1117-21.
10
Practice tips. Preventing hip fractures in elderly patients.实践提示。预防老年患者髋部骨折。
Can Fam Physician. 2003 Apr;49:430-1.
引用本文的文献
1
Osteoporosis. Part I. Advanced radiologic assessment using quantitative computed tomography.骨质疏松症。第一部分。使用定量计算机断层扫描的高级放射学评估。
West J Med. 1983 Jul;139(1):75-84.
本文引用的文献
1
Epidemiology of fractures of the proximal femur in Rochester, Minnesota.明尼苏达州罗切斯特市股骨近端骨折的流行病学研究。
Clin Orthop Relat Res. 1980 Jul-Aug(150):163-71.
2
A case-control study of menopausal estrogen therapy and breast cancer.一项关于更年期雌激素疗法与乳腺癌的病例对照研究。
JAMA. 1980 Apr 25;243(16):1635-9.
3
Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.合成类固醇（Org OD 14）预防绝经后骨质疏松症的前瞻性双盲试验。
Br Med J. 1980 May 17;280(6225):1207-9. doi: 10.1136/bmj.280.6225.1207.
4
Prospective trial of oestrogen and calcium in postmenopausal women.绝经后女性雌激素与钙的前瞻性试验。
Br Med J. 1977 Sep 24;2(6090):789-92. doi: 10.1136/bmj.2.6090.789.
5
Calcitonin treatment of post-menopausal osteoporosis. Evaluation of efficacy by principal components analysis.降钙素治疗绝经后骨质疏松症。通过主成分分析评估疗效。
Biomedicine. 1975 May;22(3):223-32.
6
Changes in bone mineral content in women with natural menopause during treatment with female sex hormones.自然绝经女性在接受性激素治疗期间骨矿物质含量的变化。
Acta Obstet Gynecol Scand. 1978;57(5):435-7. doi: 10.3109/00016347809156525.
7
Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.接受孕激素治疗的绝经后女性子宫内膜癌发病率降低。
J Am Geriatr Soc. 1979 Sep;27(9):389-94. doi: 10.1111/j.1532-5415.1979.tb01673.x.
8
Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.
Clin Sci Mol Med. 1978 Feb;54(2):193-5. doi: 10.1042/cs0540193.
9
Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.通过总骨矿物质质量变化评估甲睾酮对绝经后骨质流失的影响。
Metabolism. 1977 Mar;26(3):267-77. doi: 10.1016/0026-0495(77)90073-7.
10
Role of calcium regulating hormones in the pathogenesis of senile osteoporosis.钙调节激素在老年性骨质疏松症发病机制中的作用。
Endocrinol Jpn. 1979 Jun;26(Suppl):1-6. doi: 10.1507/endocrj1954.26.supplement_1.
Zotero 插件